<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

TATA CONSUMER PRODUCTS LIMITED

NSE: TATACONSUM · Lot size: 550

TATA CONSUMER PRODUCTS LIMITED Open Interest & PCR Analysis

1,126.1Updated 21 Apr 2026, 01:26 pm IST
PCR
1.01
Neutral
Max Pain
1,100
Spot above by ₹26
Total CE OI
2.39M
Call writers
Total PE OI
2.42M
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish

Data as of 2026-04-18

Frequently Asked Questions

What is TATA CONSUMER PRODUCTS LIMITED PCR (Put-Call Ratio) today?
TATA CONSUMER PRODUCTS LIMITED's current PCR is 1.01. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. TATA CONSUMER PRODUCTS LIMITED's PCR of 1.01 indicates neutral sentiment.
What is TATA CONSUMER PRODUCTS LIMITED OI buildup type today?
TATA CONSUMER PRODUCTS LIMITED is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for TATA CONSUMER PRODUCTS LIMITED?
TATA CONSUMER PRODUCTS LIMITED has total CE (call) OI of 2389750 contracts and total PE (put) OI of 2423300 contracts for the nearest expiry. The PCR is 1.01.
How is open interest analysis useful for TATA CONSUMER PRODUCTS LIMITED trading?
OI analysis for TATA CONSUMER PRODUCTS LIMITED helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for TATA CONSUMER PRODUCTS LIMITED?
TATA CONSUMER PRODUCTS LIMITED's max pain is ₹1,100 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.